Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents

References

• Barnett AH, Cradock S, Fisher M, et al. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract 2010;64:1121-9
   PubMed Web of Science ®Google Scholar
• Wild D, von Maltzahn R, Brohan E, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007;68:10-15
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Inzucchi SE, Bergenstal RM, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:157715-96
   Google Scholar
• Burge MR, Chelliah A, Schade DA. Hypoglycemia in type 2 diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental and Clinical Text, 3rd edn. Philadelphia, USA: Lippincott Williams & Wilkins, 2004, 83:1213-24
   Google Scholar
• Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002;51:724-33
   PubMed Web of Science ®Google Scholar
• Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002;45:937-48
   PubMed Web of Science ®Google Scholar
• Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005;28:2948-61
   PubMed Web of Science ®Google Scholar
• UK Hypoglycemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
   PubMed Web of Science ®Google Scholar
• Cryer PE. The barrier of hypoglycaemia in diabetes. Diabetes 2008;57:3169-76
   PubMed Web of Science ®Google Scholar
• Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008;10(Suppl 1):25-32
   PubMed Web of Science ®Google Scholar
• Tschöpe D, Bramlage P, Binz C, et al. Incidence and predictors of hypoglycaemia in type 2 diabetes – an analysis of the prospective DiaRegis registry. BMC Endocr Disord 2012;12:23
   PubMed Web of Science ®Google Scholar
• Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147:386-99
   PubMed Web of Science ®Google Scholar
• Fisher M. Hypoglycaemia in patients with type 2 diabetes: minimizing the risk. Br J Diabetes Vasc Dis 2010;10:35-41
   Google Scholar
• Gangji AS, Cukierman T, Gerstein HC, et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events. A comparison of glyburide with other secretagogues and with insulin. Diabetes Care 2007;30:389-94
   PubMed Web of Science ®Google Scholar
• Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983;24:412-17
   PubMed Web of Science ®Google Scholar
• Campbell IW. Sulfonylureas and hypoglycemia. Diabetic Hypoglycemia 2009;2:3-10
   Google Scholar
• Wright AD, Cull CA, Macleod KM, Holman RR; for the UKPDS Group. Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73. J Diabetes Complications 2006;20:395-401
   PubMed Web of Science ®Google Scholar
• , Action to Control Cardiovascular Risk in Diabetes Study GroupGerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• Krobot KJ, Ferrante SA, Davies MJ, et al. Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value. Curr Med Res Opin 2012;28:1281-7
   PubMed Web of Science ®Google Scholar
• Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1121-7
   PubMed Web of Science ®Google Scholar
• Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 1989;18:103-21
   PubMed Web of Science ®Google Scholar
• Dickerson RN, Hamilton LA, Connor KA, et al. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support. Nutrition 2011;27:766-72
   PubMed Web of Science ®Google Scholar
• Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev 2008;24:353-63
   PubMed Web of Science ®Google Scholar
• Frier BM, Schernthaner G, Heller SR. Hypoglycemia and cardiovascular risks. Diabetes Care 2011;34(Suppl 2):S132-7
   PubMed Web of Science ®Google Scholar
• Choudhary P, Amiel SA. Hypoglycaemia: current management and controversies. Postgrad Med J 2011;87:298-306
   PubMed Web of Science ®Google Scholar
• Waheed N, Butt M, Dayan C. Hypoglycaemia documented with real-time continuous glucose sensing in a case of ‘dead in bed’ syndrome. Pract Diabetes Int 2013;30:33-5
   Google Scholar
• Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909
   PubMed Web of Science ®Google Scholar
• Unger J. Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes 2012;5:57-74
   PubMedGoogle Scholar
• ; ADVANCE Collaborative GroupPatel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72
   PubMed Web of Science ®Google Scholar
• Duckworth WC, Abraira C, Moritz TE, et al.; Investigators of the VADT. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications 2011;25:355-61
   PubMed Web of Science ®Google Scholar
• Desouza C, Salazar H, Cheong B, et al. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003;26:1485-9
   PubMed Web of Science ®Google Scholar
• Hsu P-F, Sung S-H, Cheng H-M, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes. A nationwide population-based study. Diabetes Care 2013;36:894-900
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89
   PubMed Web of Science ®Google Scholar
• Zhang Q, Marrett E, Jameson K, et al. Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study. BMC Endocr Disord 2011;11:17
   PubMedGoogle Scholar
• Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997;20:135-41
   PubMed Web of Science ®Google Scholar
• Marker JC, Cryer PE, Clutter WE. Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes 1992;41:671-8
   PubMed Web of Science ®Google Scholar
• Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care 2012;35:2650-64
   PubMed Web of Science ®Google Scholar
• Brice R, Langerman H, Barnett AH, James J. A pharmacy-led patient survey suggests significant deficiencies in education regarding the risks of hypoglycaemia in sulphonylurea-treated patients with type 2 diabetes. Abstract presented at the Diabetes UK 2013 Professional Conference, Manchester, UK, 13–15 March, 2013
   Google Scholar
• Punthakee Z, Miller ME, Launer LJ, et al.; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35:787-93
   PubMed Web of Science ®Google Scholar
• Sinclair A, Morley JE, Rodriguez-Mañas L, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497-502
   PubMed Web of Science ®Google Scholar
• Salti I, Benard E, Detournay B, et al.; the EPIDIAR Study Group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-11
   PubMed Web of Science ®Google Scholar
• Aravind SR, Al Tayeb K, Ismail SB, et al.; 2009 Ramadan Study Group. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin 2011;27:1237-42
   PubMed Web of Science ®Google Scholar
• Hassanein M, Hanif W, Malik W, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Curr Med Res Opin 2011;27:1367-74
   PubMed Web of Science ®Google Scholar
• Aravind SR, Ismail SB, Balamurugan R, et al. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin 2012;28:1289-96
   PubMed Web of Science ®Google Scholar
• Al Sifri S, Basiounny A, Echtay A, et al.; 2010 Ramadan Study Group. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract 2011;65:1132-40
   PubMed Web of Science ®Google Scholar
• Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010;33:1895-902
   PubMed Web of Science ®Google Scholar
• Hui E, Bravis V, Hassanein M, et al. Management of people with diabetes wanting to fast during Ramadan. BMJ 2010;340:1407-11
   Web of Science ®Google Scholar
• Ahmad J, Pathan MF, Jaleel MA, et al. Diabetic emergencies including hypoglycemia during Ramadan. Indian J Endocrinol Metab 2012;16:512-15
   Google Scholar
• Aldasouqi S, Sheikh A, Klosterman P, et al. Hypoglycemia in patients with diabetes on antidiabetic medications who fast for laboratory tests. Diabetes Care 2011;34:e52
   PubMedGoogle Scholar
• Kerr D, Macdonald IA, Heller SR, Tattersall RB. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with Type 1 (insulin-dependent) diabetes. Diabetologia 1990;33:216-21
   PubMed Web of Science ®Google Scholar
• Huang Z, Sjöholm A. Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms. Endocrinology 2008;149:232-6
   PubMed Web of Science ®Google Scholar
• Burge MR, Zeise T-M, Sobhy TA, et al. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose. Diabetes Care 1999;22:2037-43
   PubMed Web of Science ®Google Scholar
• Frier BM. Impaired hypoglycaemia awareness. In: Frier BM, Fisher M, eds. Hypoglycaemia in Clinical Diabetes, 2nd edn. Chichester: John Wiley & Sons, 2007:141-70
   Google Scholar
• Lundkvist J, Berne C, Bolinder B, Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005;6:197-202
   PubMedGoogle Scholar
• Frier BM. How hypoglycaemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008;24:87-92
   PubMed Web of Science ®Google Scholar
• Williams SA, Shi L, Brenneman SK, et al. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. J Diabetes Complications 2012;26:399-406
   PubMed Web of Science ®Google Scholar
• Vexiau P, Mavros P, Krishnarajah G, et al. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008;10:16-24
   PubMed Web of Science ®Google Scholar
• Marrett E, Radican L, Davies MJ, Zhang Q. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: a survey study. BMC Res Notes 2011;4:251
   PubMedGoogle Scholar
• Holmes CS, Hayford JT, Gonzalez JL, Weydert JA. A survey of cognitive functioning at difference glucose levels in diabetic persons. Diabetes Care 1983;6:180-5
   PubMed Web of Science ®Google Scholar
• Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Progressive hypoglycemia’s impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000;23:163-70
   PubMed Web of Science ®Google Scholar
• Cox DJ, Gonder-Frederick L, Clarke W. Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes 1993;42:239-43
   PubMed Web of Science ®Google Scholar
• DVLA. Information for drivers with diabetes treated by non insulin medication, diet, or both. Available at: http://www.direct.gov.uk/prod_consum_dg/groups/dg_digitalassets/@dg/@en/@motor/documents/digitalasset/dg_067957.pdf [Last accessed November 2012]
   Google Scholar
• Brod M, Pohlman B, Wolden M, Christensen T. Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being. Qual Life Res 2013;22:997-1004
   Google Scholar
• Veneman T, Mitrakou A, Mokan M, et al. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993;42:1233-7
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ 2012;15:77-86
   PubMedGoogle Scholar
• Curkendall SM, Zhang B, Oh KS, et al. Incidence and cost of hypoglycemia among patients with type 2 diabetes in the United States: analysis of a health insurance database. J Clin Outcomes Manage 2011;18:455-62
   Google Scholar
• Hex N, Bartlett C, Wright D, et al. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine 2012;29:855-62
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
   PubMed Web of Science ®Google Scholar
• Hammer M, Lammert M, Mejías SM, et al. Costs of managing severe hypoglycaemia in three European countries. J Med Econ 2009;12:281-90
   PubMedGoogle Scholar
• Brackenridge A, Wallbank H, Lawrenson RA, Russell-Jones D. Emergency management of diabetes and hypoglycaemia. Emerg Med J 2006;23:183-5
   PubMed Web of Science ®Google Scholar
• Farmer AJ, Brockbank KJ, Keech ML, et al. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med 2012;29:1447-50
   PubMed Web of Science ®Google Scholar
• Nirantharakumar K, Marshall T, Kennedy A, et al. Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized. Diabet Med 2012;29:e445-8
   PubMed Web of Science ®Google Scholar
• Hospital Episode Statistics. Available at: http://www.hesonline.nhs.uk [Last accessed March 2013]
   Google Scholar
• Skyler JS, Bergenstal R, Bonow RO, et al.; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 2009;53:298-304
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. NICE clinical guideline 87. Type 2 diabetes. The management of type 2 diabetes. Available at: http://www.nice.org.uk/nicemedia/live/12165/44320/44320.pdf [Last accessed 11 March 2013]
   Google Scholar
• Freckmann G, Schmid C, Baumstark A, et al. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol 2012;6:1060-75
   PubMedGoogle Scholar
• American Diabetes Association. Statement by the American Diabetes Association on the Need for FDA Regulation of Blood Glucose Test Strips July 31, 2013. Available at: https://professional.diabetes.org/News_Display.aspx?TYP=9&CID=93129 [Last accessed August 2013]
   Google Scholar
• Cryer PE. Hypoglycaemia in type 2 diabetes. In: Goldstein BJ, Müller-Wieland D, eds. Type 2 Diabetes Principles and Practice, 2nd edn. New York, NY: Informa Healthcare, 2008:232
   Google Scholar
• Walsh J, Robert R, Varma C, Bailey T. Using insulin. San Diego: Torrey Pines Press; 2003
   Google Scholar